Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies.
about
Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus® Insulin Glargine.Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus.Insulin analogues in type 1 diabetes mellitus: getting better all the time.Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens.Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.Euglycaemic glucose clamp: what it can and cannot do, and how to do it.Introduction of biosimilar insulins in Europe.Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine.Insulin's Role in Diabetes Management: After 90 Years, Still Considered the Essential "Black Dress".Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.Switching basal insulins in type 2 diabetes: practical recommendations for health care providers.LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels.How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.Pharmacological Agents Utilized in Patients With Type-2 Diabetes: Beyond Lowering A1c.A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation study
P2860
Q33732607-DC4B8F2C-9E7C-4CD4-8A8F-0115924C14C0Q37561045-54553D32-B6D8-4439-899A-A1AFDC1AC2E6Q38692387-98C03D37-8EF8-4BB4-A0D4-9FCC20D21081Q38844536-37B1D26E-A45C-4FCC-8ADA-6D82D9FBACC4Q38858785-66F2285C-5A47-421D-819E-09C425B881DBQ38871135-AFAE392D-AA0B-436E-9D09-10BBF96E2030Q39368850-C814AC47-9925-4E83-A770-514866FCACF8Q40125071-9559A1FA-1219-43F8-8360-487B6754A247Q43158349-209AD6D8-EB63-42EC-99BE-95F4BEC23FF9Q46199321-1E59A673-3F8D-437C-9078-F58E85459320Q48088343-352FFF90-2BA2-4F4A-96C0-76EF5BA5C91EQ49899858-7714E72E-916F-4D0E-93B9-8067C7CA2CC6Q50131255-222C81A4-141D-49B4-B983-DC84B62301EDQ52580579-27BF5F65-3584-48A1-9B96-DB27D8D28658Q52591845-5D9F009E-1143-4D50-8688-368C16B4CEA7Q52603694-4F543FDB-2D17-4066-BA17-08658C020FD4Q55162068-E9CE8D53-9F00-47DA-8822-1DCDE8F7757AQ58763121-CCE19DA7-3F99-486E-9A59-8C6A26DB8FD8
P2860
Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@en
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@nl
type
label
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@en
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@nl
prefLabel
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@en
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@nl
P2093
P356
P1433
P1476
Comparison of the Pharmacokine ...... ized Euglycemic Clamp Studies.
@en
P2093
Chew Lan Chong
Danny Soon
David Coutant
Eric Chen Quin Lam
Helle Linnebjerg
Laiyi Chua
Maria M Ferreira
Mary E Seger
P304
P356
10.2337/DC14-2623
P407
P577
2015-08-25T00:00:00Z